contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dagens-aktienyheder-2307-embla-medical-tidligere-ossur

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying patient care. Headquartered in Iceland, the company employs over 4,000 people located across 36 countries worldwide. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.  

Embla Medical

Dagens aktienyheder med Embla Medical (tidligere Össur)

Embla Medical (tidligere &#xd6;ssur) har her til morgen aflagt H1 2024 regnskab, hvor selskabet leverer organisk v&#xe6;kst p&#xe5; 6% og realiserer en oms&#xe6;tning p&#xe5; USD 217 mio. i andet kvartal af 2024. Det er en smule bedre end forventningerne p&#xe5; USD 216 mio. V&#xe6;ksten p&#xe5; 6% skal ses i forhold til en sv&#xe6;r sammenligningsbase, hvor kvartalet sidste &#xe5;r leverede 11% v&#xe6;kst. Indtjeningsm&#xe6;ssigt leverer selskabet i kvartalet et EBITDA resultat p&#xe5; USD 47 mio. (EBITDA margin p&#xe5; 22%), hvilket er p&#xe5; niveau med forventningerne i markedet. Fremgangen i indtjeningen vs. sidste &#xe5;r er prim&#xe6;rt drevet af bedre bruttomargin, som er trukket af omkostningsoptimeringer i produktionen samt delvist bedre produktmix og &#xf8;get oms&#xe6;tning til at absorbere omkostninger. Dermed leverer selskabet p&#xe5; tidligere udmeldinger om, at marginen kunne forbedres p&#xe5; optimering i produktionen efter at have lidt under forsyningsk&#xe6;de-udfordringer i de seneste par &#xe5;r. Selskabet indsn&#xe6;vrer (l&#xf8;fter) guidance efter resultaterne for f&#xf8;rste halv&#xe5;r. Der forventes nu en organisk v&#xe6;kst p&#xe5; 6-8% (tidl. 5-8%) samt en EBITDA margin p&#xe5; ca. 20% (tidl. 19-20%). Af yderligere store begivenheder er den helt overskyggende sidste uges melding om, at de amerikanske myndigheder (CMS) har udvidet d&#xe6;kningen, s&#xe5; mindre aktive patienter ogs&#xe5; under visse foruds&#xe6;tninger kan f&#xe5; adgang til avancerede l&#xf8;sninger, hvilket forventes at udvide patientpopulationen markant. S&#xe6;rligt dette kan komme i fokus i dag, n&#xe5;r ledelsen kl. 13:00 pr&#xe6;senterer og svarer p&#xe5; sp&#xf8;rgsm&#xe5;l p&#xe5; et online live-event. Tilmeld dig og stil dine sp&#xf8;rgsm&#xe5;l her her.&#xa0;<a class="x1i10hfl xjbqb8w x1ejq31n xd10rxx x1sy0etr x17r0tee x972fbf xcfux6l x1qhh985 xm0m39n x9f619 x1ypdohk xt0psk2 xe8uvvx xdj266r x11i5rnm xat24cr x1mh8g0r xexx8yu x4uap5 x18d9i69 xkhd6sd x16tdsg8 xggy1nq x1a2a7pz x1heor9g x1bvjpef xujl8zx" tabindex="-1" role="link" href="https://www.inderes.dk/videos/embla-medical-presentation-of-interim-report-q2-2024?fbclid=IwZXh0bgNhZW0CMTAAAR0ahXTPCW187xEUiCKpE7QHLrMkitgLyPnZVNVVnG0VDQMed5p49wOjHXI_aem_8szS_SfVer2078DDb70XqQ" target="_blank" rel="nofollow noopener noreferrer">https://www.inderes.dk/videos/embla-medical-presentation-of-interim-report-q2-2024</a> Disclaimer: HC Andersen Capital modtager betaling fra selskabet for en Digital IR aftale - Kasper Lihn - 23/07-2024 kl. 8:59.

Embla Medical

Stay up to date with our newsletter